Iliac Vein Stenosis Treated With IVUS-Guided Angioplasty and Stent Placement
By Dr. Joseph G. Magnant, MD, FACS, RPVI
Patient age
37 years • Female
Overview
Case Narrative
A 37-year-old female presented with pelvic discomfort including dyspareunia and lower-extremity fatigue/heaviness, particularly after prolonged standing.
Given concern for iliac venous outflow obstruction with pelvic venous congestion physiology, she underwent intravascular ultrasound (IVUS) evaluation of the left common iliac vein (L-CIV). IVUS planimetry demonstrated a severe focal L-CIV stenosis with reference cross-sectional area (CSA) 159.4 mm² and minimal CSA 41.3 mm², corresponding to an approximate 74% area reduction (Fig 1).
The IVUS analysis summary documented approximately 74% area reduction and 93% blood-flow reduction at the test site (Fig 2), consistent with hemodynamically significant iliac obstruction and correlating with her pelvic symptom complex.
She subsequently underwent iliac venography/fluoroscopy-guided intervention. Initial pelvic imaging documented baseline catheter positioning and pre-treatment appearance (Fig 3). The lesion was crossed and treated in standard stepwise fashion with working views confirming positioning for intervention (Fig 4), followed by angioplasty across the stenotic segment (Fig 5-6).
Completion imaging demonstrated the deployed iliac venous stent framework with restoration of inline outflow (Fig 7). Post-stent IVUS confirmed a markedly expanded lumen with post-stent CSA 192.4 mm² min diameter 11.7 mm, max diameter 20.1 mm), supporting an excellent technical result (Fig 8). The IVUS summary screen reported substantial post-intervention improvement metrics (Fig 2).
At 1-month follow-up, the patient reported overall clinical improvement, including improved dyspareunia and improved leg fatigue/heaviness with prolonged standing, consistent with clinical success in addition to documented radiographic/IVUS success.
She remained on therapeutic anticoagulation post-procedure, with a brief interruption of approximately 2 days during menses due to heavy menstrual bleeding, after which anticoagulation was resumed and planned to continue for the next couple of months per protocol.
She noted persistent dysmenorrhea during her first post-stent menstrual cycle, with counseling that pelvic venous congestion symptoms may continue to improve over subsequent months as pelvic collateral burden diminishes.